| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.7 | 0.0005 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.67 | 0.0007 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |